Pragna Group

India Founded: 2017 • Age: 9 yrs
Manufactures and exports high-quality speciality chemicals, agro intermediates, dyes intermediates, and API intermediates globally.

About Pragna Group

Pragna Group is a Healthcare company based in India founded in 2017. It manufactures and exports high-quality speciality chemicals, agro intermediates, dyes intermediates, and API intermediates globally. It operates on a B2B model in Healthcare and Chemicals & Materials sectors. The company has 43 employees. Its Indian entity Pragna Life Science Private Limited reported revenue of β‚Ή12.46 Cr. Pragna Group offers products and services including Speciality Chemicals & Agro Intermediates, Dyes Intermediates, and API Intermediates. Its focus areas include Chemicals, API Intermediates, Pharmaceutical and API.

Company details

Pragna Group, established in 1999 and promoted by trade experts, is a leading manufacturer and exporter of high-quality intermediates for speciality chemicals, agro chemicals, dyes, and API. Operating from manufacturing facilities in Ankleshwar, India, with a marketing office in Canada, they emphasize safety, environmental compliance, and quality standards. They serve global clients through reliable production and transparent business practices, focusing on custom synthesis and toll manufacturing.

Key Metrics
  • Annual Revenue
    ₹12.46 Cr

    FY 2024 · +2% YoY

  • Net Profit
    ₹89.5 Lakh

    FY 2024 · 7% margin

  • EBITDA
    ₹2.28 Cr

    FY 2024 · 18% margin

  • Employee Count
    43

Products & Services of Pragna Group

Pragna Group offers a comprehensive portfolio of products and services, including Speciality Chemicals & Agro Intermediates, Dyes Intermediates, and API Intermediates.

Speciality Chemicals & Agro Intermediates
Chemical Manufacturing

Intermediates for production of speciality and agro chemicals

Dyes Intermediates
Dye Production

Raw materials used in dyes manufacturing processes

API Intermediates
Pharmaceutical Manufacturing

Intermediates for active pharmaceutical ingredients development

Board of directors of Pragna Life Science Private Limited (Pragna Group)

Pragna Life Science Private Limited is the primary company behind Pragna Group. The board of Pragna Life Science Private Limited currently have 4 directors; the longest-serving is Jigneshkumar Kalidas Patel, appointed in 2012. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Jigneshkumar Kalidas Patel
DIN 05268889
Director26 Jun 201214 yrs 3 moPragna Life Science Private Limited
Dipakkumar Shankarlal Patel
DIN 06444940
Director04 Feb 201412 yrs 8 moPragna Life Science Private Limited
Chiragkumar Ambalal Patel
DIN 08718606
Director20 Aug 20206 yrs 2 moPragna Life Science Private Limited
Maheshkumar Jivanlal Patel
DIN 00632466
Additional Director21 Feb 20251 yr 7 moPragna Life Science Private Limited

Financials of Pragna Group

Figures of Pragna Life Science Private Limited, the primary company behind Pragna Group, for FY 2024. Revenue was ₹12.46 Cr (+2% year on year). Net profit was ₹89.5 Lakh (7% margin). EBITDA was ₹2.28 Cr (18% margin). Revenue has grown at a compounded annual rate of -14% over three years and -2% over five years.

  • ₹12.46 CrRevenue · FY 2024 · +2% YoY
  • ₹89.5 LakhNet profit · 7% margin
  • ₹2.28 CrEBITDA · 18% margin
  • ₹1.00 CrPaid-up capital
  • 43Employees (provident fund records)
  • -14%Revenue CAGR, 3 years
  • -2%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Pragna Life Science Private Limited are on its company page.

Premium access

Detailed financial statements for Pragna Group

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

10 companies that operate in the same segment as Pragna Group (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 213.52 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Pragna Group

Pragna Group was founded in 2017.

Pragna Group is headquartered in India.

Pragna Group has 43 employees.

The primary company behind Pragna Group, Pragna Life Science Private Limited, reported revenue of β‚Ή12.46 Cr for FY 2024, up 2% year on year.

Pragna Group, established in 1999 and promoted by trade experts, is a leading manufacturer and exporter of high-quality intermediates for speciality chemicals, agro chemicals, dyes, and API. Operating from manufacturing facilities in Ankleshwar, India, with a marketing office in Canada, they emphasize safety, environmental compliance, and quality standards. They serve global clients through reliable production and transparent business practices, focusing on custom synthesis and toll manufacturing.

Pragna Group offers Speciality Chemicals & Agro Intermediates, Dyes Intermediates, and API Intermediates.

Pragna Group operates through Pragna Life Science Private Limited.

The legal entities of Pragna Group currently have 4 directors, including Maheshkumar Jivanlal Patel, Dipakkumar Shankarlal Patel, Jigneshkumar Kalidas Patel and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available